Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Dermapharm AG holds a company patent portfolio in the Medical Devices & Mechanical Engineering technology area. Currently, the portfolio has 1 pending office action. This action represents the focus of the company's efforts to secure patent protection for its medical technologies. The prosecution activity is limited to this outstanding matter.
The administrative oversight for this portfolio is provided by 1 distinct examiner and 1 distinct art unit. This suggests that the company's medical device assets are being evaluated within the assigned technical framework. For practitioners, this means that the prosecution strategy must be tailored to the standards of this 1 distinct art unit. There is no diversification of examiner perspectives across the workload.
LEE, DAVINA EN-YIN is the busiest examiner assigned to this portfolio, currently managing 1 busiest examiner pending office action. Since there is 1 pending office action in total, this examiner is the decision-maker for the company's active applications. Practitioners should focus on the technical concerns raised by LEE, DAVINA EN-YIN in the Medical Devices & Mechanical Engineering field.
The presence of 1 distinct art unit ensures that the examination of the company's claims remains consistent. With 1 pending office action, the legal team can focus its resources on resolving this matter. This prosecution environment avoids the risk of conflicting requirements from different examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, DAVINA EN-YIN | 1 | 38.6% | +14.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17419565 | MOBILE ITCHING TREATMENT DEVICE WITH INTERFACE | LEE, DAVINA EN-YIN | 81d overdue |
| Art Unit | Apps |
|---|---|
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17419565 | MOBILE ITCHING TREATMENT DEVICE WITH INTERFACE | LEE, DAVINA EN-YIN | 3794 | §103 | Final Rejection | 81d overdue | Pending | Jun 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial